
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. At Braeburn, we challenge the status quo and champion transformation of the manage...
Braeburn's Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Plymouth Meeting, Pennsylvania, United States
Website
Founded Year
2012
Headcount
51 - 200
Specialties
PharmaceuticalsBiotech
Braeburn's Competitors
Brenner pharma/food Business Development Ltd.
Israel
Speciality European Pharma
London, United Kingdom
Village Pharmacy Charlton Limited
Bio-start
London, United Kingdom
Nehir Biyoteknoloji
Employee Insights
Employee Function
Employee Location
Braeburn's Top Employees
Ralph Diaper
Owner
Paul Johnson
Chief Commercial Officer
Mike Derkacz
President and CEO
Louis Ricigliano
Chief Financial Officer
David McIntyre
EVP, Chief Financial Officer & Treasurer
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding Braeburn
Where is Braeburn's headquarter located?
Braeburn's headquarter are located at United States.
How many employees does Braeburn have?
Braeburn has 51 - 200 employees.
What is Braeburn's official website?
Braeburn's official website is https://braeburnrx.com
What industry does Braeburn belong to?
Braeburn is in the industry of Pharmaceutical Manufacturing
What does Braeburn do?
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. At Braeburn, we challenge the status quo and champion transformation of the manage...
What specialty does Braeburn have?
PharmaceuticalsBiotech
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
